Health Bulletin 28/September/2022

Published On 2022-09-28 12:06 GMT   |   Update On 2022-12-15 09:24 GMT

Here are the top health news for the day:


As dengue starts to sting again in Delhi, 184 high-risk areas under focus

As the dengue cases are increasing steadily, officials have identified 184 areas where the possibility of the spread of vector-borne diseases and mosquito breeding are at a peak.

For this, the state government, along with the Municipal Corporation of Delhi and New Delhi Municipal Council, has unveiled a campaign on checking mosquito breeding, strengthening health facilities, and roping in schoolchildren, departmental officials, and residents' welfare associations to create an awareness on the spread of disease, and its prevention. 

Advertisement


No medical negligence in treating Hirschprung Disease yet HC orders state to pay Rs 5 lakh compensation

The Madurai bench of Madras High Court recently directed the State for paying Rs 5 lakh compensation to the family of a boy who died during treatment at Government Rajaji Hospital in Madurai.

Although the bench comprising of Justice R. Vijayakumar noted that there was no medical negligence on the part of the doctors who had treated the patient, the compensation was awarded by the court as it took note of the fact that the patient had been treated at the GMC for four years.

For more details, check out link given below:

No Medical Negligence In Treating Hirschprung Disease Yet HC Orders State To Pay Rs 5 Lakh Compensation


Doctors move SC over cancellation of AIIMS INI CET counselling

Upset with the cancellation of further rounds of INI CET PG medical counselling in the Institutes of National Importance, the doctors have now approached the Supreme Court seeking relief.

Referring to the notice issued by All India Institute of Medical Sciences (AIIMS) New Delhi on September 19, 2022, the doctors under the umbrella of Federation of All India Medical Association (FAIMA) have also written to the AIIMS director and pointed out more than 50% vacant seats in multiple departments of various institutes.

For more details, check out link given below:

Doctors Move SC Over Cancellation Of AIIMS INI CET Counselling


Amid confusion on NMC fee order, PG medical education in Maharashtra gets costlier

While there is no clarity regarding the implementation of National Medical Commission's fee order for 50 percent private medical college seats, the Postgraduate medical education in Maharashtra has become costlier this year after several deemed-to-be medical institutes hiked their annual fees for certain courses.

Fees have been increased by as much as Rs 10 lakh annual for certain courses, adds HT. With this, the PG medical aspirants wishing to pursue their course in MD Radio-diagnosis or dermatology at MGM Medical College will have to pay Rs 35 lakh per annum. The fees for these courses at MGM Medical College was earlier Rs 25 lakh.

For more details, check out link given below:

Amid Confusion On NMC Fee Order, PG Medical Education In Maharashtra Gets Costlier


Torrent Pharma to buy Curatio healthcare for Rs 2,000 crores

Torrent Pharmaceuticals Limited has entered into definitive agreements to acquire 100% of Curatio Healthcare (I) Private Limited (Curatio) for Rs. 2,000 crores. The consideration includes Rs. 115 crores (on the date of signing) of cash and cash equivalents in the acquired business indicating an Enterprise Value of Rs. 1,885 crores.

Curatio's portfolio consists of leading brands such as Tedibar, Atogla, Spoo, B4 Nappi, and Permite. The top ten brands of Curatio account for ~75% of total revenue. With this acquisition, Torrent Pharma will add a Field Force of 600 MRs and a distribution network of 900 stockists.

For more details, check out link given below:

Torrent Pharma To Buy Curatio Healthcare For Rs 2,000 Crores

Full View
Tags:    

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News

Health Bulletin 29/ June/ 2024
Health Bulletin 28/ June/ 2024
Health Bulletin 27/ June/ 2024
Health Bulletin 26/ June/ 2024
Health Bulletin 25/ June/ 2024
Health Bulletin 24/ June/ 2024
Health Bulletin 22/ June/ 2024
Health Bulletin 21/ June/ 2024